Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Valneva SE

Start price
Target price
Perf. (%)
€11.85
08.07.21
-
08.07.22
-11.18%
08.07.22

Saftman 
08.07.21 50%
sell
Abivax S.A.

Start price
Target price
Perf. (%)
€30.50
28.06.21
€25.00
28.06.22
-16.39%
01.12.21

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Snowman 
28.06.21 50%
sell
Valneva SE

Start price
Target price
Perf. (%)
€10.89
17.06.21
€8.00
17.06.22
3.21%
20.07.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
melinda 
17.06.21 50%
buy
Advicenne

Start price
Target price
Perf. (%)
€8.74
30.05.21
€10.00
30.05.22
-10.98%
31.08.21

Could be worthwhile Investment >10% per year
melinda 
30.05.21 50%
sell
Valneva SE

Start price
Target price
Perf. (%)
€14.89
03.05.21
-
03.05.22
-24.78%
20.09.21

Letue35 
03.05.21 0%
sell
Virbac S.A.

Start price
Target price
Perf. (%)
€275.00
28.04.21
€270.00
28.04.22
43.82%
25.10.21

Could be worthwhile Investment >10% per year
melinda 
28.04.21 40%
buy
Adocia

Start price
Target price
Perf. (%)
€9.09
26.04.21
-
26.04.22
1.54%
09.08.21

DropStone 
26.04.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€13.02
19.04.21
-
19.04.22
14.36%
03.05.21

Letue35 
19.04.21 0%
sell
Virbac S.A.

Start price
Target price
Perf. (%)
€279.00
19.04.21
-
19.04.22
35.48%
20.04.22

Letue35 
19.04.21 0%
sell
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€5.98
17.04.21
€2.00
17.04.22
1.00%
01.05.21

mixitrader 
17.04.21 50%
sell
Boiron S.A.

Start price
Target price
Perf. (%)
€38.55
13.04.21
€36.00
13.04.22
-1.30%
26.11.21

Could be worthwhile Investment >10% per year
melinda 
13.04.21 50%
buy
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€6.45
10.03.21
-
10.03.22
-19.53%
15.08.21

CerealKiller 
10.03.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€10.68
07.03.21
€11.00
07.03.22
26.50%
07.03.22

balearn 
07.03.21 60%
buy
Advicenne

Start price
Target price
Perf. (%)
€13.60
14.02.21
€14.00
14.02.22
-35.74%
30.05.21

Could be worthwhile Investment >10% per year
melinda 
14.02.21 50%
sell
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€9.15
30.01.21
-
30.01.22
-67.40%
08.01.22

Trip 
30.01.21 50%
sell
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€8.16
15.01.21
-
15.01.22
-63.58%
16.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
shadow 
15.01.21 0%
buy
Boiron S.A.

Start price
Target price
Perf. (%)
€37.60
13.01.21
€41.00
13.01.22
2.53%
13.04.21

Could be worthwhile Investment >10% per year
melinda 
13.01.21 50%
sell
Adocia

Start price
Target price
Perf. (%)
€10.02
12.01.21
-
12.01.22
-19.86%
13.01.22

Letue35 
12.01.21 0%
sell
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€6.12
10.01.21
-
10.01.22
-50.90%
11.01.22

PlusUltra 
10.01.21 60%
buy
Avadel Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€6.70
15.12.20
€7.00
15.12.21
-3.73%
16.12.21

melinda 
15.12.20 50%
sell
Innate Pharma

Start price
Target price
Perf. (%)
€3.61
14.12.20
-
14.12.21
1.50%
06.04.21

Washer 
14.12.20 50%
buy
Adocia

Start price
Target price
Perf. (%)
€7.54
16.11.20
€10.00
16.11.21
18.04%
17.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
yester 
16.11.20 50%
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.10
15.11.20
€5.50
15.11.21
7.86%
16.11.21

Could be worthwhile Investment >10% per year
melinda 
15.11.20 50%
sell
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€3.80
07.11.20
-
07.11.21
131.05%
15.07.21

Biotechhunter 
07.11.20 50%
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€3.45
03.11.20
-
04.11.21
136.51%
15.01.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
shadow 
03.11.20 50%